iSpecimen

ISPC · NASDAQ

$0.9599−$0.0415 (−4.14%)TodayMarket closed ·
Prev close $1.00

Latest news

  • NewsRishabh Mishra

    Stock Market Today: S&P 500, Dow, Nasdaq 100 Futures Fall as Oil Tops $99 Despite Trump’s Price Drop Prediction— ASML, NVS, CASY in Focus (UPDATED)

  • News

    12 Health Care Stocks Moving In Friday's Intraday Session

  • NewsAvi Kapoor

    Dow Jumps 350 Points; BJ's Wholesale Club Posts Upbeat Earnings

  • News

    12 Health Care Stocks Moving In Friday's Pre-Market Session

  • Press releaseNewsfile

    iSpecimen Completes Large-Scale International Cancer Research Order; Samples Shipped Within Three Weeks

  • Press releaseGlobe Newswire

    iSpecimen Completes Large-Scale International Cancer Research Order; Samples Shipped Within Three Weeks

  • News

    12 Health Care Stocks Moving In Wednesday's After-Market Session

  • News

    12 Health Care Stocks Moving In Friday's Pre-Market Session

  • NewsAvi Kapoor

    Why Twilio Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket

  • NewsAvi Kapoor

    Dow Jumps Over 600 Points; Netflix Shares Tumble After Q1 Results

  • News

    12 Health Care Stocks Moving In Friday's Pre-Market Session

  • NewsMohd Haider

    iSpecimen Is Trending Overnight — Here's Why ISPC Stock Surged 56% In The After-Hours Session

  • News

    12 Health Care Stocks Moving In Thursday's After-Market Session

  • Press releaseNewsfile

    iSpecimen Achieves 85% Reduction in Human Biospecimen Shipping Time

  • News

    12 Health Care Stocks Moving In Monday's After-Market Session

  • News

    12 Health Care Stocks Moving In Friday's After-Market Session

  • NewsAvi Kapoor

    Dow Gains Over 300 Points; US GDP Growth Revised Lower In Q4

  • News

    12 Health Care Stocks Moving In Friday's Pre-Market Session

  • NewsMohd Haider

    iSpecimen (ISPC) Stock Rockets 43% After Hours — Here's Why It's Trending

  • Press releaseNewsfile

    iSpecimen Launches AI Agent Revolutionizing Biospecimen Matching

  • Press releaseGlobe Newswire

    iSpecimen Launches AI Agent Revolutionizing Biospecimen Matching

  • News

    12 Health Care Stocks Moving In Monday's Intraday Session

  • News

    12 Health Care Stocks Moving In Friday's Pre-Market Session

  • News

    12 Health Care Stocks Moving In Thursday's After-Market Session

  • NewsAvi Kapoor

    Why Vanda Pharmaceuticals Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket

  • NewsVishaal Sanjay

    Stock Market Today: S&P 500, Dow Jones Futures Down As Santa Rally Hopes Fade—Investors Await Initial Jobless Claims Report

  • NewsMohd Haider

    iSpecimen Inc (ISPC) Stock Surged 42% After-Hours: Here's The News Behind The Move

  • News

    12 Health Care Stocks Moving In Monday's After-Market Session

  • NewsAvi Kapoor

    Why Oracle Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket

  • News

    12 Health Care Stocks Moving In Friday's Pre-Market Session

  • NewsAvi Kapoor

    Why Docusign Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket

  • Press releaseNewsfile

    iSpecimen Approached by Crypto Currency Companies for $200 Million Treasury Discussions

  • News

    12 Health Care Stocks Moving In Friday's After-Market Session

  • News

    12 Health Care Stocks Moving In Friday's Intraday Session

  • News

    12 Health Care Stocks Moving In Friday's Pre-Market Session

  • News

    12 Health Care Stocks Moving In Thursday's After-Market Session

  • Press releaseNewsfile

    iSpecimen to Establish $200M Corporate Treasury Built Around Solana Cryptocurrency with BlockArrow

  • NewsRishabh Mishra

    US Stocks Likely To Open Higher Ahead of Trump's Inaugration: All 11 Sectors To Report Growing Profits In 2025, Says Analyst

  • NewsAvi Kapoor

    Why Versus Systems Shares Are Trading Higher By Around 71%; Here Are 20 Stocks Moving Premarket

  • News

    iSpecimen Secures Suppliers For hMPV Biospecimens Amid Rising Concerns Of COVID-Style Pandemic In China; Leverages Global Network For Anticipated Vaccine Development Amid Growing Specimen Demand

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.